Republicans and Democrats alike have made it clear that they have no interest in cutting Medicare benefits. But the status quo is not fiscally sustainable.
The Inflation Reduction Act’s drug price controls may be popular. But by discouraging companies from investing in innovative, accessible drugs, they’ll harm current and future patients in need of effective therapies.
The American healthcare system outperforms the government-dominated systems of comparable countries on any meaningful metric. Simply put, there’s no better place to get sick than the United States.
Banning facility fees may seem like a straightforward way to reduce patients’ medical bills. But it will do so by killing off clinics—and thereby curtailing patient access to care.
QALYs are a pseudoscientific and inhumane way to make decisions about medical treatment. In countries where regulators rely on these metrics to determine patient access to drugs, they almost exclusively lead to the denial of life-saving treatments.
Telemedicine and direct primary care can help patients access affordable, quality care. Taken together, they offer a way out of the costly and confusing status quo—and a vision of what American health care could one day be.
Fewer effective drugs will make the Cancer Moonshot’s goal of halving the cancer death rate over the next 25 years a lot harder to achieve—if not impossible.
Hopefully Americans will look at the human tragedies unfolding in Canada and Great Britain—and make clear to progressive lawmakers that they have no interest in Medicare for All here.